JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics

Area of Science:

• Virology
• Immunology
• Neuroscience

Background:

• JC polyomavirus (JCPyV) establishes asymptomatic kidney infections in most people.
• Reactivation in immunocompromised individuals leads to fatal progressive multifocal leukoencephalopathy (PML).
• Limited therapeutic options exist for PML.

Purpose of the Study:

• To review current knowledge of JCPyV attachment and entry mechanisms.
• To explore potential therapeutic targets for preventing or treating PML by inhibiting these initial steps.

Main Methods:

• Literature review of JCPyV infection pathways.
• Analysis of host-pathogen interactions.
• Evaluation of emerging therapeutic strategies.

Main Results:

• JCPyV utilizes α2,6-linked lactoseries tetrasaccharide c (LSTc) for attachment and 5-hydroxytryptamine receptors (5-HT₂Rs) for entry.
• Endoplasmic reticulum trafficking is essential for JCPyV infection.
• Vaccines, monoclonal antibodies, and small molecules show therapeutic potential.

Conclusions:

• Understanding JCPyV attachment, entry, and trafficking is crucial for PML therapeutic development.
• Targeting these viral processes presents a viable strategy for combating PML.